COMP <GO>
MMSI vs ABBV // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Merit Medical Systems Inc. (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: MMSI 7
— ABBV 8
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: MMSI
LAST: $86.24 (-7.66%) • MKT CAP: $5.58B
options-implied-move
6.70%
LAST: $294.89 (+1.41%) • MKT CAP: $513.86B
options-implied-move
7.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MMSI VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MMSI | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 48.70% | 70.20% | -21.50 | ABBV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.80% | 29.00% | -21.20 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation | 23.1x | 33.3x | -10.20 | MMSI | /valuation <GO> |
| Free Cash Flow Yield | 3.87% | 3.47% | +0.40 | MMSI | /fcf-yield <GO> |
| Operating Margin | 12.20% | 24.60% | -12.40 | ABBV | /operating-margins <GO> |
| Net Profit Margin | 8.50% | 6.90% | +1.60 | MMSI | /net-margins <GO> |
| Revenue Growth (YoY) | 11.80% | 8.60% | +3.20 | MMSI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.62 | 5.33 | -0.71 | ABBV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | MMSI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 6.70% | 7.40% | -0.70 | MMSI | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.3 | 72.8 | -31.51 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.94 | 1.15 | -0.21 | ABBV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 40.4x | 113.1x | -72.70 | MMSI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.58B | $513.86B | -$508.28B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MMSI REV | ABBV REV | MMSI GROSS % | ABBV GROSS % | MMSI FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.52B | $61.16B | 48.7% | 70.2% | $215.7M | $17.82B |
| FY 2024 | $1.36B | $56.33B | 47.4% | 70.0% | $185.7M | $17.83B |
| FY 2023 | $1.26B | $54.32B | 44.0% | 44.0% | $88.6M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MMSI // BETA 0.94
ABBV // BETA 1.15